Trends in direct oral anticoagulant (DOAC) use:Health benefits and patient preference

In 2012, the Dutch Health Council published a report addressing barriers for an early and broad introduction of direct oral anticoagulants (DOACs). The report raised concerns about the lack of an antidote, adherence, lack of monitoring in the case of overdose and the increased budget impact at DOAC introduction. In the past decade, international studies have shown that DOACs can provide healthcare benefits for a large number of patients. This has led to an increase in the prescription of DOACs, as they are an effective and user-friendly alternative to vitamin K antagonists (VKAs). Unlike VKAs,... Mehr ...

Verfasser: de Jong, L.A.
Koops, M.
Gout-Zwart, J.J.
Beinema, M.J.
Hemels, M.E.W.
Postma, M.J.
Brouwers, J.R.B.J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: de Jong , L A , Koops , M , Gout-Zwart , J J , Beinema , M J , Hemels , M E W , Postma , M J & Brouwers , J R B J 2018 , ' Trends in direct oral anticoagulant (DOAC) use : Health benefits and patient preference ' , Netherlands Journal of Medicine , vol. 76 , no. 10 , pp. 426-430 .
Schlagwörter: Coumarins / DOAC / Health benefits / NOAC / Patient preferences / VKA / adult / budget / controlled study / drug overdose / drug therapy / human / international normalized ratio / monitoring / Netherlands / patient preference / pharmacokinetics / prescription / review / antidote / antivitamin K / coumarin derivative
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26825917
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/900b46a8-41f2-470c-a350-9d56a1331f2e